Regimen Optimization Study

NCT02137239 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Transplantation

Interventions

DRUG: Thymoglobulin
DRUG: Belatacept
DRUG: mycophenolate mofetil(MMF)
DRUG: Corticosteroids
DRUG: Everolimus(EVL)
DRUG: Tacrolimus(TAC)

Sponsor

Bristol-Myers Squibb